In April 2016 Manchester eScholar was replaced by the University of Manchester’s new Research Information Management System, Pure. In the autumn the University’s research outputs will be available to search and browse via a new Research Portal. Until then the University’s full publication record can be accessed via a temporary portal and the old eScholar content is available to search and browse via this archive.

Natural history of azathioprine-associated lymphopenia in inflammatory bowel disease patients: a prospective observational study.

Al Rifai, Ahmad; Prasad, Neeraj; Shuttleworth, Elinor; McBurney, Helen; Pushpakom, Sudeep; Robinson, Andrew; Newman, William; Campbell, Simon

European journal of gastroenterology & hepatology. 2011;23(2):153-8.

Access to files

Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:

Full-text held externally

Abstract

INTRODUCTION: Azathioprine (AZA) is commonly used in inflammatory bowel disease (IBD) patients. Lymphopenia is a recognized effect of this treatment, but lymphopenia-related complications in IBD patients have not been widely reported. The incidence and progression of AZA-induced lymphopenia in IBD patients is not well described. There is no consensus on its optimal management in this group. AIMS AND METHODS: We assessed the incidence and progression of lymphopenia and its related complications in a cohort of IBD patients over a 14-month period in two large tertiary gastroenterology units. Analysis of prospectively collected data was performed. RESULTS: Fifty-two patients were studied prospectively with a median age of 34 years. Eighteen patients (34.6%) developed lymphopenia (<1.0Ă—10(9)/l) during the course of treatment and 10 of them had severe lymphopenia (<0.6Ă—10(9)/l). Lymphopenia lasted on average 85.4 days and spontaneously resolved in 13 patients. No lymphopenia related-complications were documented. Patients treated with steroids had a significantly higher rate of lymphopenia (83.3 vs. 44.1%, P=0.0083). CONCLUSION: Lymphopenia is common among IBD patients treated with AZA. However, it did not seem to be associated with a higher risk of opportunistic infections and spontaneously resolved in the majority of cases.

Bibliographic metadata

Type of resource:
Content type:
Publication type:
Published date:
Abbreviated journal title:
ISSN:
Place of publication:
England
Volume:
23
Issue:
2
Pagination:
153-8
Digital Object Identifier:
10.1097/MEG.0b013e32834233a2
Pubmed Identifier:
21164349
Access state:
Active

Institutional metadata

University researcher(s):

Record metadata

Manchester eScholar ID:
uk-ac-man-scw:132941
Created by:
Newman, William
Created:
12th October, 2011, 14:40:25
Last modified by:
Newman, William
Last modified:
10th April, 2013, 20:07:56

Can we help?

The library chat service will be available from 11am-3pm Monday to Friday (excluding Bank Holidays). You can also email your enquiry to us.